The majority of cells in many triple-negative breast cancer cell lines were shown to be CD44+/CD24−/low cells, and tumorigenic potential was not tightly correlated with the percentage of the CD44+/CD24−/low subpopulation [6]. This evidence concerns the gene CD44 and triple-negative breast carcinoma.